Biotech

All Articles

Atea's COVID antiviral neglects to stop hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has actually failed another COVID-19 test, yet the biotech still ho...

Neurocrine's offer to spare schizophrenia possibility stops working

.Neurocrine Biosciences' mental illness program pivot has stopped working. The biotech was not able ...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has actually made a late access to the radioligand gathering, paying for 100 thousand euros ...

F 2G brings up $100M for second try to get brand new antifungal to market

.After F2G's initial effort to obtain a new class of antifungal to market was derailed due to the FD...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 plans in the middle of success tensions

.Moderna has promised to reduce R&ampD investing by $1.1 billion by 2027. The choice to shrink the b...

Sanofi's $80M bet on Key dystrophy drug finishes in phase 3 go belly up

.Merely 4 months after Sanofi wager $80 thousand in beforehand cash on Fulcrum Therapeutics' losmapi...

Oncternal share sinks 60% surrounded by unemployments, test firings

.Cancer firm Oncternal Therapeutics is actually folding all its clinical tests and also giving up wo...

Roche is keeping out chances that its own injectable excessive weight possibility can eventually show 25% weight reduction in late-stage trial

.Roche is actually storing out hopes that its injectable being overweight possibility can ultimately...

Novo Nordisk barrages 'remarkable' weight reduction lead for dual-acting oral medication in early trial

.Novo Nordisk has actually lifted the lid on a stage 1 test of its dental amylin as well as GLP-1 re...

AbbVie sues BeiGene over blood stream cancer medicine classified information

.Only a handful of short full weeks after winning an FDA Fast lane tag for its own investigational B...